Ngai Suk Wai, Fan Susan, Li Shiqin, Cheng Linan, Ding Juhong, Jing Xiaoping, Ng Ernest Hung Yu, Ho Pak Chung
Department of Obstetrics & Gynecology, University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong SAR, China.
Hum Reprod. 2005 Jan;20(1):307-11. doi: 10.1093/humrep/deh583. Epub 2004 Nov 26.
Levonorgestrel (0.75 mg given for two doses 12 h apart) has been proven to be an effective regimen for emergency contraception when the first dose is given within 72 h of unprotected coitus. However, the dosing interval is inconvenient for those taking the first dose in the afternoon. We conducted a randomized study to evaluate two levonorgestrel dosing regimens for emergency contraception. Two doses of levonorgestrel 0.75 mg were administered with the first dose given up to 120 h after unprotected intercourse. The second dose was given 12 h later in the first regimen and 24 h later in the second regimen.
We conducted a double-blind, randomized trial between 1997 and 2003 at five centres in China. A total of 2071 women requesting emergency contraception within 120 h of unprotected intercourse were recruited. They were randomized to receive two doses of 0.75 mg of levonorgestrel, given either 24 h apart or 12 h apart.
Outcome was unknown for 53 women (24 in the 24 h group and 29 in the 12 h group). Among the remaining 2018 women, the crude pregnancy rate was 1.9% in the 24 h group [95% confidence interval (CI) 1.17-2.94] and 2.0% in the 12 h group (95% CI 1.19-2.99). The proportion of pregnancies prevented was estimated to be 72% in the 24 h group and 75% in the 12 h group. Side-effects were mild in both groups. The efficacy of the 12 h regimen declined significantly when there were further acts of intercourse after treatment (5.0 versus 1.0%, P<0.01). This was not observed in the 24 h group.
Two doses of 0.75 mg levonorgestrel given either 24 or 12 h apart are effective for emergency contraception up to 120 h after unprotected intercourse. Further research to investigative more effective methods of emergency contraception is warranted.
左炔诺孕酮(0.75毫克,分两剂,间隔12小时给药)已被证明是一种有效的紧急避孕方案,前提是在无保护性交后72小时内服用第一剂。然而,给药间隔对于那些在下午服用第一剂的人来说不太方便。我们进行了一项随机研究,以评估两种左炔诺孕酮紧急避孕给药方案。两剂0.75毫克左炔诺孕酮在无保护性交后长达120小时内服用第一剂。在第一种方案中,第二剂在12小时后给药,在第二种方案中,第二剂在24小时后给药。
1997年至2003年期间,我们在中国的五个中心进行了一项双盲随机试验。总共招募了2071名在无保护性交后120小时内要求紧急避孕的女性。她们被随机分为接受两剂0.75毫克左炔诺孕酮,给药间隔为24小时或12小时。
53名女性(24小时组24名,12小时组29名)的结果未知。在其余2018名女性中,24小时组的粗妊娠率为1.9%[95%置信区间(CI)1.17 - 2.94],12小时组为2.0%(95%CI 1.19 - 2.99)。24小时组预防妊娠的比例估计为72%,12小时组为75%。两组的副作用均较轻。治疗后若有进一步性交行为,12小时方案的疗效显著下降(5.0%对1.0%,P<0.01)。24小时组未观察到这种情况。
两剂0.75毫克左炔诺孕酮,给药间隔为24小时或12小时,在无保护性交后长达120小时内用于紧急避孕均有效。有必要进行进一步研究以探索更有效的紧急避孕方法。